Dr. Svetislava Judith Vukelja MD Medical Oncologist

Dr. Svetislava Vukelja is a medical oncologist in Tyler, Texas and is affiliated with Mother Frances Hospital - Tyler. She received her medical degree from Uniformed Services University of the Health Sciences and has been in practice for 27 years. Dr. Vukelja accepts several types of health insurance, listed below. She is one of 6 doctors at Mother Frances Hospital - Tyler who specialize in Medical Oncology.

Are you Dr. Svetislava Vukelja? Claim your profile to make edits or add details. Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Medical Oncologist: General Oncology

Hospital Affiliation

Mother Frances Hospital - Tyler

Education & Medical Training

Walter Reed Army Medical Center
Residency, Internal Medicine, 1983 - 1986

Walter Reed Army Medical Center
Fellowship, Medical Oncology, 1986 - 1989

Uniformed Services University of the Health Sciences
Class of 1983

Certifications & Licensure

American Board of Internal Medicine
Certified 28 years in Internal Medicine

American Board of Internal Medicine
Certified 26 years in Hematology

American Board of Internal Medicine
Certified 25 years in Medical Oncology

TX State Medical License
Active through 2014

Awards, Honors & Recognition

Meaningful Use Stage 1 Certification, Centers for Medicare & Medicaid Services
2012

Publications & Presentations

Phase II randomized trial of weekly and every-3-week ixabepilone in metastatic breast cancer patients.
Smith, J. W.,Vukelja, S.,Rabe, A.,Wentworth-Hartung, N.,Koutrelakos, N.,Shao, S. H.,Whittaker, T.,Wang, Y.,Asmar, L.,McDowell, D. O.,Mukhopadhyay, P.,O'Shaughnessy, J.

Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study.
Jones, S. E.,Collea, R.,Paul, D.,Sedlacek, S.,Favret, A. M.,Gore, I.,Lindquist, D. L.,Holmes, F. A.,Allison, M. A.,Brooks, B. D.,Portillo, R. M.,Vukelja, S. J.,Steinberg, M. S.,Stokoe, C.,Crockett, M. W.,Wang, Y.,Asmar, L.,Robert, N. J.,O'Shaughnessy, J.

Phase II study of the antibody drug conjugate trastuzumab-DM1 for the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer after prior HER2-directed therapy.
Burris, H.A., Rugo, H.S., Vukelja, S.J., Vogel, C.L., Borson, R.A., Limentani, S., Tan-Chiu, E., Krop, I.E., Michaelson, R.A., Girish, S., Amler, L., Zheng, M., Chu, Y., Klencke, B., O'Shaughnessy, J.A.

See all 37 publications

Insurances Accepted

  • Aetna Choice POS II
  • BCBS Blue Card PPO
  • BCBS Texas BlueChoice
  • CIGNA Open Access
  • CIGNA PPO
  • Great West PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO
Find More Doctors
Doctor Finder

Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Browse Doctors by

Specialty

Location

Search all Doctors

Profiles by Doximity

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.